Navigation Links
WNDM President Interviewed; Discusses 2011 Outlook and Beyond
Date:5/19/2011

FORT WORTH, Texas, May 19, 2011 /PRNewswire/ -- Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in advanced wound care solutions announced the publication of an interview of its President Deborah Jenkins Hutchinson by CEOCFOInterviews.com, a weekly web publication consisting of interviews with CEOs and CFOs of publicly traded growth companies.

Topics within the interview, conducted by Lynn Fosse, Senior Editor, CEOCFOInterviews.com include why Ms. Jenkins Hutchinson joined the Company, how and why the Company's FDA approved flagship product, CellerateRX®, has become a primary treatment for all types of wounds (except 3rd degree burns) and the reasons why the investment community is beginning to take notice of the public company's common stock (WNDM: OTCQB).

In the interview, the Wound Management President summarizes the Company's progress by stating, "Wound Management Technologies is growing and hitting its milestones. It will be cash flow positive, and it will be profitable.  We are doing what we said we were going to do and we believe Wound Management Technologies is going to emerge into quite a strong company."

The interview can be accessed at either;
http://ceocfointerviews.com/interviews/WNDM-WoundManagement11.htm or within the newly reconfigured Wound Management Technologies website http://www.wmgtech.com.  For more information on the Company and/or to be added to the Company's investor email list, please call our investor relations office at 917-974-9872 or enter your name and email address in the "Get WNDM News" area at the top of the Company's website.

About Wound Management Technologies, Inc.

Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare data collaboration and storage.  More information can be found on the company's web sites: http://www.wmgtech.com and http://www.celleraterx.com.

Follow us on: FACEBOOK | TWITTER | LINKEDIN

Safe Harbor Statement:

The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

For Wound Management Technologies Shareholder Information please call (917) 974-9872 or visit http://www.wmgtech.com


'/>"/>
SOURCE Wound Management Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PLC Medical Systems Adds Vice President of Clinical Affairs
2. Anaphore Appoints Michael F. Haller, Ph.D., Senior Vice President of Strategic Partnerships and H Casey Logan Senior Vice President of Business Development
3. U.S. Chamber Inducts PCMA President & CEO Mark Merritt to its Committee of Top Trade Assoc. Executives
4. eCardio Diagnostics Announces Three Executive Appointments to Chief Operating Officer, Chief Technology Officer and Executive Vice President
5. Medivance President and CEO Robert Kline Named Ernst & Young Entrepreneur Of The Year® 2011 Mountain Desert Region Award Finalist
6. Abaxis Receives Presidential "E" Award for Exports
7. Precyse Secures Healthcare IT Executive Chris Powell as New President
8. The Board of Directors of Kinex Pharmaceuticals Appoints Dr. Allen Barnett as President Emeritus and Dr. Johnson Lau as Chief Executive Officer
9. Avanir Pharmaceuticals Announces Appointment of Elona Kogan, Esq. as Vice President of Legal Affairs
10. Delcath Names Harold C. Mapes as Executive Vice President of Global Operations
11. Nonin Medical Announces Mark VanderWerf, Vice President-eHealth, Elected to American Telemedicine Association College of Fellows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Story Highlights: ... the health care industry is causing providers to review ... Deloitte offers a suite of solutions for health care ... cost optimization: labor resource analysis, revenue cycle optimization and ... outcomes and better economics ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
Breaking Medicine News(10 mins):